3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Solid Tumors
4
Relapsed Pediatric Solid Tumor
2
Refractory Solid Tumors
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Unspecified Adult Solid Tumor - Protocol Specific
1
Solid Tumours
1
Solid Tumor, Adult
1
Solid Tumor
1
Refractory or Recurrent Solid Tumor
1
Advanced Cancers
1
Interventions
spartalizumab
1
pazopanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Refractory or Recurrent Solid Tumor
×
pazopanib
×
Other solid neoplasm
×
Clear all
NCT05210413
2026-01-15
SPARTO
University Hospital, Bordeaux
Phase 1/2
Active not recruiting
80 enrolled